Literature DB >> 11745933

Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees.

J Bukh1, C L Apgar, S Govindarajan, R H Purcell.   

Abstract

GB virus-B (GBV-B) is a member of the Flaviviridae family of viruses. This RNA virus causes acute resolving hepatitis in experimentally infected tamarins, but its natural host remains unknown. GBV-B and a related virus, GBV-A, were recovered from serum containing the "GB agent," which was believed to have originated from a surgeon (initials: GB) with acute hepatitis. GBV-B has special interest because it is the virus related most closely to hepatitis C virus, which is an important cause of acute and chronic liver disease in humans. In the present study, we found that the host range of GBV-B includes owl monkeys. Tamarins and owl monkeys belong to two different families of New World monkeys. The natural history of GBV-B in the two owl monkeys studied was similar to that previously found for tamarins and was characterized by early appearance of viremia and viral clearance. However, the peak viral titers of GBV-B observed in owl monkeys (10(5) genome equivalents [GE] /ml) were lower than those observed in experimentally infected tamarins (10(7)-10(8) GE/ml) and acute hepatitis was observed in only one animal. If GBV-B were indeed a virus of humans, it would be expected to infect chimpanzees, a surrogate of humans, because all recognized human hepatitis viruses are transmissible to chimpanzees and cause hepatitis. However, in the present study, we failed to transmit GBV-B to a naive chimpanzee. In addition, a second naive chimpanzee transfected intrahepatically with RNA transcripts from an infectious clone of GBV-B did not become infected. Thus, chimpanzees are apparently not susceptible to GBV-B. Finally, we failed to detect GBV-B in acute-phase serum from surgeon GB. Our data suggest that GBV-B is not a human virus and that GBV-B, like GBV-A, is a virus of New World monkeys. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11745933     DOI: 10.1002/jmv.2092

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  39 in total

1.  Characterization of a canine homolog of hepatitis C virus.

Authors:  Amit Kapoor; Peter Simmonds; Gisa Gerold; Natasha Qaisar; Komal Jain; Jose A Henriquez; Cadhla Firth; David L Hirschberg; Charles M Rice; Shelly Shields; W Ian Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-24       Impact factor: 11.205

2.  Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.

Authors:  Cordelia Manickam; Premeela Rajakumar; Lynn Wachtman; Joshua A Kramer; Amanda J Martinot; Valerie Varner; Luis D Giavedoni; R Keith Reeves
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  Characterisation of Mhc class I and class II DRB polymorphism in red-bellied tamarins (Saguinus labiatus).

Authors:  Edward T Mee; James Greenhow; Nicola J Rose
Journal:  Immunogenetics       Date:  2011-06-17       Impact factor: 2.846

Review 4.  Murine models of hepatitis C: what can we look forward to?

Authors:  Markus von Schaewen; Alexander Ploss
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

5.  Bats are a major natural reservoir for hepaciviruses and pegiviruses.

Authors:  Phenix-Lan Quan; Cadhla Firth; Juliette M Conte; Simon H Williams; Carlos M Zambrana-Torrelio; Simon J Anthony; James A Ellison; Amy T Gilbert; Ivan V Kuzmin; Michael Niezgoda; Modupe O V Osinubi; Sergio Recuenco; Wanda Markotter; Robert F Breiman; Lems Kalemba; Jean Malekani; Kim A Lindblade; Melinda K Rostal; Rafael Ojeda-Flores; Gerardo Suzan; Lora B Davis; Dianna M Blau; Albert B Ogunkoya; Danilo A Alvarez Castillo; David Moran; Sali Ngam; Dudu Akaibe; Bernard Agwanda; Thomas Briese; Jonathan H Epstein; Peter Daszak; Charles E Rupprecht; Edward C Holmes; W Ian Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

6.  The marmoset model of GB virus B infections: adaptation to host phenotypic variation.

Authors:  Trudie Weatherford; Deborah Chavez; Kathleen M Brasky; Robert E Lanford
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies.

Authors:  Célia Boukadida; Caroline Marnata; Roland Montserret; Lisette Cohen; Brigitte Blumen; Jérôme Gouttenoire; Darius Moradpour; François Penin; Annette Martin
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

8.  Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein.

Authors:  Shingo Takikawa; Ronald E Engle; Suzanne U Emerson; Robert H Purcell; Marisa St Claire; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  Hallmarks of hepatitis C virus in equine hepacivirus.

Authors:  Tomohisa Tanaka; Hirotake Kasai; Atsuya Yamashita; Kaori Okuyama-Dobashi; Jun Yasumoto; Shinya Maekawa; Nobuyuki Enomoto; Toru Okamoto; Yoshiharu Matsuura; Masami Morimatsu; Noboru Manabe; Kazuhiko Ochiai; Kazuto Yamashita; Kohji Moriishi
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

10.  A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B.

Authors:  Lucile Warter; Lisette Cohen; Yann Benureau; Deborah Chavez; Yan Yang; Francis Bodola; Stanley M Lemon; Cinzia Traboni; Robert E Lanford; Annette Martin
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.